tirzepatide semaglutide comparison Cardiovascular outcomes of and for patients with type 2 diabetes in clinical practice Tirzepatide vs. Semaglutide for Weight

This combination of effects typically results in significant weight loss over time

Unlike earlier weight-management medicines, retatrutide is a triple receptor agonist , meaning it simultaneously targets three distinct hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors

(GLP-1 stands for glucagon-like peptide-1, a natural hormone that people produce in their guts

It also tends to create more air bubbles as it warms in the syringe

You may be a good candidate if you check any of these boxes: You have been diagnosed with Type 2 diabetes You have a body mass index (BMI) of: 30 or higher (obese), or 27 or higher (overweight) with at least one weight-related condition, such as hypertension, type 2 diabetes, or dyslipidemia

You do not have to have diabetes to participate